Rainbow Children's Medicare (RAINBOW) investor relations material

Executive summary

• Revenue for Q1 FY26 grew 6.9% year-over-year to ₹3,529.3 million, with EBITDA up 10.6% and PAT up 35.4% to ₹538.1 million, despite Q1 being seasonally softer for pediatric volumes.

• The hospital network expanded to 20 hospitals across 7 cities, with 2,035 beds and over 925 doctors.

• Newer hospitals contributed in line with expectations, and a 76% stake was acquired in Prashanthi Hospital, Warangal, expanding the network into tier-2 cities.

• The company continues to focus on scalable growth, clinical excellence, and expansion into new geographies, including NCR, Pune, and the Northeast.

• Unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, were approved by the Board on July 26, 2025.

Financial highlights

• Consolidated revenue from operations for Q1 FY26 was ₹3,529.3 million, up 6.9% year-over-year; PAT rose 35.4% to ₹538.1 million; EBITDA margin improved to 29.4%.

• Outpatient volumes grew 6%, inpatient and deliveries grew 12% year-over-year; ARPOB for Q1 FY26 was ₹58,057, up 13% YoY.

• IVF segment revenue grew 50% year-over-year, now contributing 3.2% of total revenue.

• Employee benefits expense grew 5.4% YoY; professional fees to doctors up 8% YoY.

• Final dividend of Rs. 3 per share (Rs. 304.66 million total) for FY25 was paid on July 5, 2025.

Outlook and guidance

• Expansion plans include new hospitals in Hennur, Electronic City, Coimbatore, Gurugram, and Rajahmundry, targeting 2,865 beds by FY28, with 250+ beds to be added in the next 2-3 months.

• Revenue growth guidance remains in the high teens to 20% range for the coming years.

• Pune greenfield hospital project is expected to commence operations in 2.5 years, with CapEx of around INR 80 lakhs per bed.

• Employee Stock Option Scheme 2025 (ESOP 2025) was approved, with 140,810 stock options granted to eligible employees.